Oxis International

Oxis International,Inc. is the premiere company which provides the potent antioxidants, Ergothioneine and pure l-ergothioneine through thier patented synthetic manufacturing process, worldwide.
The products of the company include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates. The company is focused on  naturally occurring protective substances since they are more likely to be both safe and efficacious.

The primary products of Oxis incorporate and emphasize the multifaceted “super antioxidant” compound, L- Ergothioneine (“ERGO”) , GLUTATHIONE PEROXIDASE (GPX) as a key component. the company owns several patents and pending applications related to ERGO that cover current  and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address  ERGO’s protective effects and activities and the ERGO manufacturing process. It produces the compounds which TREAts OXIDATIVE STRESS  by controlling free radicles and hence it is very helpful as an anti aging compound as well.

Oxis is listed under the category of penny stocks which can be a great opportunity for inverstors.Investers can contact us through our website for more information.

To know more about us visit :http://www.oxis.com